Peter Kies Inovio Pharmaceuticals, Inc. (INO) insider trading activity

Peter Kies is CFO of INOVIO PHARMACEUTICALS, INC.. Currently has a direct ownership of 24,367 shares of INO, which is worth approximately $217,597. The most recent transaction as insider was on May 15, 2024, when has been sold 2,562 shares (Common Stock) at a price of $13.07 per share, resulting in proceeds of $33,485. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.4K

9.97% 3M change

89.72% 12M change

Total Value Held $217,597

PETER KIES Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 15 2024	SELL Payment of exercise price or tax liability	$33,485 $13.07 p/Share	2,562 Reduced 9.51%	24,367 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	-	4,771 Added 15.05%	26,929 Common Stock
Feb 26 2024	SELL Payment of exercise price or tax liability	$28,282 $8.16 p/Share	3,466 Reduced 13.53%	22,158 Common Stock
Feb 26 2024	BUY Exercise of conversion of derivative security	-	5,875 Added 19.33%	24,516 Common Stock
Mar 11 2023	SELL Payment of exercise price or tax liability	$35,493 $1.13 p/Share	31,410 Reduced 11.7%	236,999 Common Stock
Mar 11 2023	BUY Exercise of conversion of derivative security	-	59,737 Added 18.2%	268,409 Common Stock
Feb 26 2023	SELL Payment of exercise price or tax liability	$52,637 $1.28 p/Share	41,123 Reduced 16.46%	208,672 Common Stock

Feb 26 2023	BUY Exercise of conversion of derivative security	-	70,511 Added 22.94%	236,867 Common Stock
Mar 11 2022	SELL Payment of exercise price or tax liability	$101,140 $3.22 p/Share	31,410 Reduced 14.91%	179,284 Common Stock
Mar 11 2022	BUY Exercise of conversion of derivative security	-	59,737 Added 22.09%	210,694 Common Stock
Mar 08 2022	SELL Payment of exercise price or tax liability	$36,796 $3.26 p/Share	11,287 Reduced 6.96%	150,957 Common Stock
Mar 08 2022	BUY Exercise of conversion of derivative security	-	21,466 Added 11.68%	162,244 Common Stock
Feb 26 2022	SELL Payment of exercise price or tax liability	$40,427 $3.22 p/Share	12,555 Reduced 8.19%	140,778 Common Stock
Feb 26 2022	BUY Exercise of conversion of derivative security	-	22,545 Added 12.82%	153,333 Common Stock
Jun 09 2021	SELL Open market or private sale	$337,838 $10.01 p/Share	33,750 Reduced 20.51%	130,788 Common Stock
Jun 09 2021	BUY Exercise of conversion of derivative security	$29,700 $2.16 p/Share	13,750 Added 7.71%	164,538 Common Stock
Jun 03 2021	SELL Open market or private sale	$80,300 $8.03 p/Share	10,000 Reduced 6.22%	150,788 Common Stock
Apr 21 2021	SELL Open market or private sale	$85,200 $8.52 p/Share	10,000 Reduced 5.86%	160,788 Common Stock
Mar 11 2021	SELL Payment of exercise price or tax liability	$332,004 $10.57 p/Share	31,410 Reduced 15.53%	170,788 Common Stock
Mar 11 2021	BUY Exercise of conversion of derivative security	-	59,737 Added 22.81%	202,198 Common Stock
Mar 08 2021	SELL Payment of exercise price or tax liability	$100,576 $8.91 p/Share	11,288 Reduced 7.34%	142,461 Common Stock
Mar 08 2021	BUY Exercise of conversion of derivative security	-	21,467 Added 12.25%	153,749 Common Stock
Mar 05 2021	SELL Payment of exercise price or tax liability	$133,935 $9.19 p/Share	14,574 Reduced 9.92%	132,282 Common Stock
Mar 05 2021	BUY Exercise of conversion of derivative security	-	27,566 Added 15.8%	146,856 Common Stock
Jan 15 2021	SELL Open market or private sale	$300,600 $10.02 p/Share	30,000 Reduced 20.1%	119,290 Common Stock

Peter Kies

CFO

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INO shares.

Notify only if

Value

Insider Trading

Get notified when an Inovio Pharmaceuticals, Inc. insider buys or sells INO shares.

Notify only if

Operation

Value

Type

News

Receive news related to INOVIO PHARMACEUTICALS, INC.

Track Activities on INO

Account